24jun9:00 amPREDiCT: Imaging Modalities for Oncology Drug DevelopmentVirtual Hosted by: Hanson Wade

Hosted by

Hanson Wade

Event Details

The progress of multimodal imaging techniques offers pharmaceutical companies the opportunity to fast-track evidence of drug response and therapeutic action. At the PREDiCT: Imaging Modalities for Oncology Drug Development Summit, they will reveal the strategy behind the multimodal applications to understand how this information can determine clinical candidate success.

Join like-minded individuals in Boston with 60+ experts alongside organizations such as National Institute of Health, Genentech, MD Anderson Cancer Institute, Bristol Myers Squibb and more. Utilize industry insight behind the latest imaging modalities to monitor immune responses in a safe and non-invasive manner, enabling you to accelerate your oncology drug development with confidence.



Jun. 24, 9 a.m.-6 p.m.



A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy